Related Information

• Termination of Declarations of Emergency Justifying Emergency Use Authorization (EUA) of Certain Antiviral Drugs—Zanamivir, Oseltamivir Phosphate, and Peramivir (PDF - 31KB)
  6/21/2010
• Peramivir Emergency Use Authorization Disposition Letter and Question and Answer Attachment

Historical Information

The information previously contained on these pages were authorized under the 2009 H1N1 Influenza Emergency Use Authorizations (EUAs).As of June 23, 2010, the EUA authorizing the use of the unapproved drug peramivir has been terminated and will no longer be in effect. The following historical information is no longer current.

• Information for Healthcare Professionals: Peramivir IV Renal Dosing Recommendations
• Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV (PDF - 114KB)
• Peramivir IV Questions and Answers for Health Care Providers
• FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings
• Peramivir Letter for Emergency Use Authorization (PDF - 65KB)
• Peramivir Patient Fact Sheet (PDF - 35KB)
• Peramivir Fact Sheet for Health Care Providers (PDF - 381KB)
• Information for Healthcare Professionals - Mandatory Adverse Event Reporting for Emergency Use of Peramivir IV Under EUA Issued 10/23/2009

Contact FDA